Patents on basic co-integrated vectors and methods – Patents granted to Max-Planck
Specific Patent Information
| Patent Number | Title, Independent Claims and Summary of Claims | Assignee | |||
|---|---|---|---|---|---|
EP 116718 B2
|
Title – Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid Ti plasmid vectors useful for this process
Designated contracting States at the time of grant are: Austria, Belgium (patent lapsed as reported on INPADOC), Switzerland (patent lapsed as reported on INPADOC), Germany, France, United Kingdom (patent lapsed as reported on INPADOC), Italy, Liechtenstein, Luxembourg, Netherlands (patent lapsed as reported on INPADOC), Sweden (patent lapsed as reported on INPADOC). The invention claimed in patent EP 116 718 B2 relates to vector combinations consisting of acceptor Ti plasmids and intermediate cloning vectors that result in the formation of a hybrid Ti plasmid. The hybrid plasmid is also claimed. In certain claims, the region between border sequences is said to be substantially free of internal T-DNA sequences of a wild type Ti plasmid. How free “substantially free” is, is not defined in the disclosure. Further, the claims do not exclude the presence of sequences from a mutated Ti plasmid. The co-integration of both plasmid types is achieved through a single crossover event. The homologous region derives from a cloning vector and is present in both the acceptor plasmid and the intermediate cloning vector. The resultant hybrid plasmid contains at least:
|
Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V. |
|||
AU 546542 B
|
Title – Introduction of exressible genes into plant genomes and Agrobacterium strains carrying hybrid Ti plasmid
The patent AU-B-546 542 claims acceptor Ti plasmids and intermediate cloning vector molecules that through a single crossover event form a co-integrated or hybrid Ti plasmid. The hybrid plasmid contains a gene of interest located between two border sequences. The resulting hybrid plasmid disclosed in both of the patents is incapable of inducing tumors in plants transformed via Agrobacterium;however, the “comprising” language used in the claims doesn’t exclude the addition of oncogenic sequences. |
||||
EP 290799 B1
|
Title – Transgenic dicotyledonous plant cells and plants
This granted patent is a divisional of now granted EP 116718 (see above). Designated contracting States at the time of grant are: Austria, Belgium (patent lapsed as reported on INPADOC), Switzerland (patent lapsed as reported on INPADOC), Germany, France, United Kingdom, Italy, Liechtenstein, Luxembourg, Netherlands (patent lapsed as reported on INPADOC), Sweden (patent lapsed as reported on INPADOC). Independent claim 1 of granted EP 290799 B2 does not claim a co-integrated vector system (see application EP 290799 A2 below), but a transformed cell of a dicotoledonous plant that:
|
||||
EP 320500 B1
|
Title – Non-oncogenic Ti plasmid vector system and recombinant DNA molecules for the introduction of expressible genes into plant cell genomes
This granted patent is a divisional of now granted EP 116718 (see above). Designated contracting States at the time of grant are: Austria (patent lapsed as reported on INPADOC), Belgium (patent lapsed as reported on INPADOC), Switzerland (patent lapsed as reported on INPADOC), Germany, France, United Kingdom, Italy, Liechtenstein, Luxembourg, Netherlands (patent lapsed as reported on INPADOC), Sweden. |
||||
EP 290799 A2
|
Title – Process for the production of expressible genes into plant cell genomes and Agrobacterium strains carrying hybrid Ti plasmid vectors useful for this process
The European application EP 290 799 A2 claims a recombinant plant genome obtained after infection of plant cells with an Agrobacteriumstrain having a hybrid Ti plasmid. The recombinant genome contains an exogenous gene of interest and is free of oncogenic sequences. The hybrid plasmid is the product of homologous recombination between an acceptor plasmid and an intermediate cloning vector. The elements of the combined acceptor plasmids and intermediate cloning vectors are set out in Claim 1. |
||||
EP 320500 A2
|
Title – Non-oncogenic Ti plasmid vector system and recombinant DNA molecules for the introduction of expressible genes into plant cell genomes
The European application EP 320 500 A2 claims a non-oncogenic Ti plasmid vector containing a gene of interest and its controlling promoter associated with at least the right border of the wild type T-region. The border allows the integration of the gene into the plant genome. Also, the Ti plasmid contains the sequences needed for transfer of T-region into plant genome (claim 1). In another independent claim, a gene of interest and its promoter that is associated with a right T-border are contained in an intermediate cloning vector (claim 4). |
||||
| Remarks |
|
Note: Patent information on this page was last updated on 28 February 2006.
